Many people with Long Covid are exploring peptides, methylene blue and other experimental treatments. This evidence-based guide explains the science behind these therapies, what research currently shows, the potential risks, and why medical supervision is essential.
Tag: long covid research
Long COVID Phenotypes Explained: Understanding the Different Types of Long COVID
Long COVID phenotypes are the different symptom patterns and biological mechanisms that make each person's experience unique. Learn about the six main Long COVID phenotypes, why they overlap, how reinfections can change them and why understanding your phenotype can help make sense of your symptoms.
Is Long Covid Permanent? What the 2026 Research Actually Says
Most people with Long Covid experience gradual improvement over twelve to twenty-four months, according to a 2025 study. However, approximately 17% may have persistent symptoms or worsening conditions. Understanding individual variations and biological factors is crucial, as ongoing research aims to develop targeted therapies. Avoiding reinfection is also essential for recovery.
Tinnitus and Vision Problems After COVID: Why Tests Are Normal
Many Covid recovery patients experience tinnitus, visual disturbances, and sensory dysregulation, often without structural abnormalities in tests. These symptoms suggest central nervous system involvement rather than local issues. While no targeted treatment exists, managing autonomic function and avoiding sensory overload may stabilize symptoms, reflecting a broader neurological pattern in Long Covid.
Immunotherapy for Long COVID: IVIG, Rituximab and Monoclonal Antibodies Explained
IVIG, rituximab and monoclonal antibodies are increasingly discussed as possible Long Covid treatments. Here is what the evidence shows, why access remains difficult and what researchers still do not know.
Can anti-CHRM autoantibodies cause Long COVID? Understanding the Link and Future Treatments
Researchers have identified anti-CHRM autoantibodies in some people with Long COVID, particularly those with autonomic symptoms such as dizziness, palpitations and brain fog. This article explains what these antibodies are, why scientists are studying them, and whether they could one day lead to better diagnosis or targeted treatments.